Intellia Therapeutics (NTLA) Stock Price

$12.17 0.7%

Sign up
to add to portfolio

AI Score

Hold

  • Alternative

    6

  • Fundamental

    1

  • Technical

    5

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Intellia Therapeutics, AI stock picks, stock alerts and much more.

Sign up

NTLA AI Stock Analysis

AI stock analysis for NTLA is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Intellia Therapeutics (NTLA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Intellia Therapeutics (NTLA) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Intellia Therapeutics (NTLA), currently trading at $12.17, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About NTLA

LSE

  • Intellia Therapeutics, Inc.

  • Symbol

    NTLA

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    1.2B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX		 $21.62
2%
6
INO Inovio Pharmaceuticals
INO		 $2.24
0.9%
2
MRNA Moderna
MRNA		 $35.53
5.3%
4
AVXL Anavex Life Sciences
AVXL		 $8.35
3.8%
6
BBIO BridgeBio Pharma
BBIO		 $36.85
0.1%
6

News

Levi & Korsinsky Reminds Intellia Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA

Levi & Korsinsky Reminds Intellia Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA
February 21, 2025. accessnewswire.com
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA

ROSEN, LEADING INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLA
February 21, 2025. globenewswire.com
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA
February 21, 2025. accessnewswire.com
Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – NTLA

Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – NTLA
February 21, 2025. globenewswire.com

NTLA Alternative Data

Web Traffic

Intellia Therapeutics receives an estimated 32655 monthly visitors to intelliatx.com.

  • Web Traffic

    32655

  • Change from Previous Month

    28.1%

  • 3 Month Change

    16.3%

  • YoY Change

    16.3%

Reddit Mentions

Intellia Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    100%

News Mentions

Intellia Therapeutics was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    100%

  • 3 Month Change

    100%

Twitter Followers

Intellia Therapeutics has 11,427 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.

  • Twitter Followers

    11427

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.6%

  • YoY Change

    0.6%

LinkedIn Followers

60,108 are following Intellia Therapeutics on LinkedIn, up by 1% over the last month.

  • LinkedIn Followers

    60108

  • Daily Change

    0%

  • 1 Month Change

    1%

  • 3 Month Change

    2.9%

Job Postings

Intellia Therapeutics currenly has an estimated 25 open job postings, up by 31.6% over the last month.

  • Job Postings

    25

  • Daily Change

    4.2%

  • 1 Month Change

    31.6%

  • 3 Month Change

    127.3%

  • YoY Change

    127.3%

LinkedIn Employees

According to LinkedIn, Intellia Therapeutics has 524 employees, down by -6.4% over the last month.

  • LinkedIn Employees

    524

  • Daily Change

    0%

  • 1 Month Change

    6.4%

  • 3 Month Change

    11.6%

  • YoY Change

    11.6%

Instagram Followers

Intellia Therapeutics has 1,248 Instagram Followers on its main Instagram account, up by 0.3% over the last month.

  • Instagram Followers

    1248

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    1.4%

  • YoY Change

    1.4%

Business Outlook

  • Business Outlook

    33

  • Change from Previous Month

    17.5%

  • 3 Month Change

    0%

  • YoY Change

    0%

NTLA Financials

NTLA Key Metrics

  • Total Revenue

    $9.1M

  • Net Income

    -$135.7M

  • Earnings per Share

    -$1.34

  • Free cash flow

    -$86.1M

  • EBITDA

    -$142.2M

  • EBITDA Ratio

    -15.6033

  • Total Assets

    $1.2B

NTLA 2-year Revenue & Income
NTLA 2-year Free Cash Flow

NTLA Technicals

NTLA SMA
NTLA RSI

FAQ

What's the current price of Intellia Therapeutics (NTLA) Stock?
The price of an Intellia Therapeutics (NTLA) share is $12.17.

What's the market cap of Intellia Therapeutics?
The current market cap of Intellia Therapeutics is 1.2B.

Should I buy or sell NTLA?
Intellia Therapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Intellia Therapeutics is better viewed as a hold or accumulate position while waiting for further developments.

Is Intellia Therapeutics a good investment?
The current analysis of Intellia Therapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Intellia Therapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Intellia Therapeutics (NTLA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Intellia Therapeutics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Intellia Therapeutics (NTLA) that investors often compare it to?
Intellia Therapeutics (NTLA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Intellia Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Intellia Therapeutics' stock price to be around $11.62 in 2026. Starting from the current price of $12.17, this represents a 4.5% change in price, indicating a bearish outlook for the stock.

How to buy Intellia Therapeutics (NTLA) Stock?
Intellia Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Intellia Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.